Drreddys Laboratories | RDY - Net Income


Drreddys Laboratories reported INR9.25B in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
ANI Pharmaceuticals USD 35.15M 10.44M Sep/2026
Aurora Cannabis CAD -4.03M 67.07M Jun/2026
Bayer EUR -672M 891M Sep/2026
Canopy Growth CAD -14.58M 142.54M Jun/2026
Cipla INR 8.78B 884.9M Sep/2026
Corcept Therapeutics USD 124.49M 82.35M Sep/2026
Drreddys Laboratories INR 9.25B 7.04B Sep/2026
GlaxoSmithKline GBP 1.54B 1.11B Sep/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Novartis USD 1.2B 2.06B Sep/2026
Pacira USD 325.3M 320.65M Sep/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 38.54M 15.39M Jun/2026
Richter Gedeon HUF 38.26B 27.02B Jun/2026
Sun Pharmaceuticals INR 19.89B 9.06B Sep/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026
Teva Pharmaceutical Industries USD 233M 809M Sep/2026